Pharmbio Korea will exclusively sell Clipper (beclomethasone dipropionate), an original ulcerative colitis treatment from Italian pharmaceutical company Chiesi, in Korea.Clipper is a steroidal ulcerative colitis treatment, a long-acting extended-release tablet that provides the anti-inflammatory ben
No fewer than 3,093 students applied for five additional medical school recruitments for the class of 2024, reaffirming a “medical school craze” that went way beyond simple concentration.Jongro Academy, a prominent extracurricular educational institute, has disclosed application details of 22 medica
Biologic agent Dupixent (dupilumab) has emerged as a new treatment option for moderate-to-severe nodular pruritic rash (prurigo nodularis), for which existing treatments, such as topical steroids and systemic immunosuppressants, have shown little treatment effects.On Wednesday, Sanofi Korea held a n
CHA Biotech said it had achieved its highest-ever annual revenue, posting a consolidated revenue of 954 billion won ($798 million) for the year 2023, up 13 percent from the previous year, thanks to strong business performance overseas.Despite the global economic slowdown, CHA Biotech attributed its
NGeneBio, a precision diagnostics platform company, has received approval from the Thai Food and Drug Administration (TFDA) to market HLAaccuTest™ All, an in vitro diagnostic medical device based on next-generation sequencing (NGS) technology.It is the fourth NGS-based product approved for registrat
Kolon Life Science said it has decided to appeal to the Supreme Court against the revocation of the manufacturing and sales license for its knee osteoarthritis cell and gene therapy, Invossa-K Inj.This move comes after the company faced defeats in both the district and appellate courts.Most recently
Biotech companies developing new drugs are plagued by rumors that adversely affect investor sentiment.Faced with a series of speculations about the equity sale by the largest shareholders and plans for a capital increase, SCM Lifescience, ABL Bio, NKMAX, and Genome & Company have responded with offi
Marking Rare Disease Day on Feb. 29, the Korea Disease Control and Prevention Agency (KDCA) held its 8th Rare Disease Day commemorative event on Wednesday to enhance public awareness of rare diseases and to encourage the determination of rare disease patients and their families to overcome illnesses
Celltrion said Thursday that it has completed submitting a marketing authorization application for CT-P47, a biosimilar to Actemra (tocilizumab) for treating autoimmune diseases, to the Ministry of Food and Drug Safety (MFDS).Celltrion has applied for the marketing authorization of CT-P47 for the fu
Severance Hospital said that Professor Kuh Sung-uk at the Department of Neurosurgery, who also teaches at Yonsei University's College of Medicine, was honored with the grand prize at the 8th Medical Device Industry Awards Ceremony.Professor Kuh also serves as head of external relations at Severance
Korea’s state health insurance system recorded a surplus for three years in a row, with accumulated reserves reaching a record 28 trillion won ($21 billion).Both income and expense increased year-on-year, but income grew more significantly. After Covid-19, hospital-level medical institutions recover
Celltrion said it has commenced the first shipment of Zymfentra, the world’s first subcutaneous form of infliximab, to the U.S. targeting autoimmune diseases. The company announced that the initial shipment batch was airlifted today to Atlanta, U.S., with plans to complete three shipment phases by e
Dentis said Wednesday that it has obtained approval from the U.S. Food and Drug Administration (FDA) for its sheet used for clear orthodontic device, “Serafin.”“MESHEET,” developed by Dentis, is a dental orthodontic sheet with a composite structure embedded with a mesh-structured cushioning mat, and
PARP (poly ADP-ribose polymerase) inhibitors have recently emerged as a new treatment option for metastatic castration-resistant prostate cancer (mCRPC) with a poor prognosis and are expected to contribute significantly to improving survival rates.However, they remain far beyond the reach of most Ko
The government plans to implement the use of "e-labels" for certain biopharmaceutical products, including the newly developed antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) and the anti-PD-1 immunotherapy Keytruda (pembrolizumab).Last Friday, the Ministry of Food and Drug Safety anno
The last day of February every year is “World Rare Disease Day.” People who decided it reportedly thought about the rarity of February, the last day of which ends on the 29th every four years, to symbolize the experiences of people with rare diseases. Korea had celebrated it on May 24 until last yea
A Korean research team, led by Professor Kim Na-young at the Department of Internal Medicine of Seoul National University Bundang Hospital (SNUBH), analyzed the differences between males and females with stomach cancer positive for the Epstein-Barr virus (EBV), which infects more than 90 percent of
In the rapidly evolving landscape of healthcare, digital therapeutics (DTx) have emerged as a groundbreaking third generation of treatment, drawing global attention as a promising sector. These software-based interventions, designed to treat diseases and enhance health much like traditional pharmace
Kakao Healthcare said over 50 health regulatory officials, including those from the Ministry of Food and Drug Safety, the WHO, and the U.S. FDA, visited its headquarters on Monday in light of the AI Regulatory and International Symposium 2024 (AIRIS 2024).The event is ongoing at the Shilla Seoul Hot
CHA Biotech has launched a study to enhance the anticancer efficacy of its natural killer (NK) cell therapeutic drug by making the most of polymer, a cationic compound.The cationic compounds used in the study are synthetic polymers, in which monomers, molecules with low molecular weight, are repeate